Characterisation of Patients With Severe Asthma in Primary and Secondary Care Settings in Europe Reported to be Eligible for Biological Therapy

Cohort Analysis of Clinical and Biological Severe Childhood Asthma

NCT02114034 ·Status: ACTIVE_NOT_RECRUITING

Patient-reported Outcomes in Real-world Use of Benralizumab in Patients With Severe Eosinophilic Asthma in Belgium

NCT04221802 ·Status: COMPLETED

Longitudinal Cohort Study in Participants With Severe Asthma to Assess Biomarkers

NCT02537691 ·Status: COMPLETED ·Phase: PHASE4

A Real-life Observational Study in Severe Eosinophilic Asthma Adult Participant Treated With Benralizumab in Italy

NCT07214753 ·Status: RECRUITING

Cross-sectional Study for Identification and Description of Severe Asthma Patients

NCT02293265 ·Status: COMPLETED ·Phase: PHASE3

Severe Asthma Network Italy

NCT06625216 ·Status: RECRUITING

A Study for Observing Severe Asthma in Patients Treated With Tezepelumab

NCT05677139 ·Status: COMPLETED

A Translational Study to Describe Clinical Characteristics, Biomarkers and to Identify Phenotypes and Endotypes Associated With Differential Outcomes in Chinese Population

NCT06419413 ·Status: RECRUITING

A Retrospective Chart Review to Investigate Clinical Remission in Patients With Severe Asthma Treated With Biologics in the United Kingdom National Health Service

NCT06261567 ·Status: COMPLETED

Investigation of Efficacy, Safety and Tolerability of Once and Twice Daily Doses of AZD1981 in Asthmatic Patients

NCT01197794 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of the Frequency of Limitation of Activity in Patients With Persistent Asthma

NCT01078688 ·Status: COMPLETED

STYLE - Symbicort Single Inhaler Therapy vs Conventional Therapy in Treatment of Persistent Asthma

NCT00252824 ·Status: COMPLETED ·Phase: PHASE3

A Phase II Study to Evaluate the Efficacy, Safety and Tolerability of AZD5069 in Patients With Uncontrolled Persistent Asthma.

NCT01704495 ·Status: COMPLETED ·Phase: PHASE2

A Study of JNJ-38518168 in Symptomatic Adult Participants With Uncontrolled, Persistent Asthma

NCT01823016 ·Status: COMPLETED ·Phase: PHASE2

ChAracterisation of ItaliaN Severe Uncontrolled Asthmatic patieNts Key Features When Receiving Benralizumab

NCT04272463 ·Status: COMPLETED

A Study to Compare Severe Asthma Patients Who Start Biologics and Who do Not Start (PROSPECT)

NCT04808518 ·Status: COMPLETED

A Study To Evaluate The Treatment Pattern Of Moderate-to-Severe Asthma Patients In China

NCT06422663 ·Status: COMPLETED

Benralizumab Patient Access Programme Study: Retrospective Study in UK Severe Asthma Centres

NCT05932849 ·Status: COMPLETED

DESOLO - SiT Peri-Launch: A Comparison of Symbicort Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma in Adults

NCT00252863 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD7594 Administered Once Daily by Inhalation in Asthmatic Subjects

NCT03622112 ·Status: COMPLETED ·Phase: PHASE2

Evaluating the Symbicort Turbuhaler (Formoterol/Budesonide) Maintenance and Reliever Therapy for Asthma in Daily Practice

NCT00782314 ·Status: COMPLETED

Multicentric, Transversal, Descriptive, Epidemiological Study on the Management of Asthma in Asthmatic Middle East Adult Population

NCT02153411 ·Status: COMPLETED

Titratable Dosing in Moderate to Severe Asthmatics

NCT00651768 ·Status: COMPLETED ·Phase: PHASE3

An Observational, Retrospective Multicentre Medical Record Review to Describe the Post-authorisation Early Clinical Experience of Dupilumab in the Treatment of Adult Severe Asthma

NCT06064526 ·Status: COMPLETED

Impact of Respiratory Allergy on Response to Initiation of Biotherapy in Severe Asthma in Adult Severe Asthmatic Patients Followed at Poitiers University Hospital on Biotherapy

NCT06916104 ·Status: ENROLLING_BY_INVITATION